Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis
Sponsor: Vanda Pharmaceuticals
Summary
This is a multicenter, open label study designed to evaluate the safety, tolerability, and efficacy of topically administered VTR-297 solution. The efficacy objectives of the study will be assessed using fungal culture testing, Neutral Red Staining (NRS) microscopy examination, and KOH microscopy examination after 4 weeks of treatment with VTR-297.
Official title: An Open Label Study to Investigate the Safety and Tolerability of Trichostatin A in Patients With Mild to Severe Onychomycosis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-05-05
Completion Date
2026-09
Last Updated
2026-02-04
Healthy Volunteers
No
Conditions
Interventions
Trichostatin A
Topical Study Drug
Locations (5)
Vanda Investigational Site
Fremont, California, United States
Vanda Investigational Site
Denver, Colorado, United States
Vanda Investigational Site
New Brighton, Minnesota, United States
Vanda Investigational Site
Pflugerville, Texas, United States
Vanda Investigational Site
Forest, Virginia, United States